Top insider buys: Jun 26 – Jul 2, 2023

The largest open-market purchases company insiders reported on SEC Form 4 between Jun 26 – Jul 2, 2023.

Week 26, 2023

#	Company	Who bought	Shares	Value	Source
1	ACET Adicet Bio, Inc.	2 officers/directors Cluster buy Carl L. Gordon, ORBIMED ADVISORS LLC	1,750,000	$3.7M	SEC filings
2	OKE ONEOK INC /NEW/	2 officers/directors Cluster buy Pierce Norton, Brian L. Derksen	29,507	$1.8M	SEC filings
3	MPAA MOTORCAR PARTS OF AMERICA INC	3 officers/directors Cluster buy BISON CAPITAL PARTNERS VI-A, L.P., BISON CAPITAL PARTNERS VI, L.P., Douglas B. Trussler	150,000	$1.1M	SEC filings
4	DMAC DiaMedica Therapeutics Inc.	3 officers/directors Cluster buy Koch Thomas Von, Randall Michael Giuffre, David J. Wambeke, Richard D. Pilnik	141,727	$554K +$5.0M by large holders	SEC filings
5	LCID Lucid Group, Inc.	Director PUBLIC INVESTMENT FUND	265,693,703	$1814.7M	SEC filings
6	OXY OCCIDENTAL PETROLEUM CORP /DE/	10% Owner BERKSHIRE HATHAWAY INC	2,138,250	$122.1M	SEC filings
7	MAX MediaAlpha, Inc.	Director WHITE MOUNTAINS INSURANCE GROUP LTD	5,916,816	$59.2M	SEC filings
8	PGIM Private Real Estate Fund, Inc.	10% Owner PRUDENTIAL FINANCIAL INC	1,897,159	$47.4M	SEC filings
9	MLTX MoonLake Immunotherapeutics	10% Owner Bihua Chen	450,000	$20.5M	SEC filings
10	RCUS Arcus Biosciences, Inc.	10% Owner GILEAD SCIENCES, INC.	1,010,000	$19.5M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.